[
    [
        {
            "time": "2018-04-15",
            "original_text": "[看好评级]医药生物行业2018年一季报业绩前瞻：稳健增长 分化明显 重点关注优质成长与稳健价值",
            "features": {
                "keywords": [
                    "医药生物",
                    "一季报",
                    "业绩前瞻",
                    "稳健增长",
                    "分化明显",
                    "优质成长",
                    "稳健价值"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业2018年一季报业绩前瞻：稳健增长 分化明显 重点关注优质成长与稳健价值",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]